CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 89 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $9,000 | -50.0% | 33,750 | 0.0% | 0.01% | -44.4% |
| Q1 2022 | $18,000 | -35.7% | 33,750 | -25.0% | 0.01% | -25.0% |
| Q4 2021 | $28,000 | -54.1% | 45,000 | -25.0% | 0.01% | -57.1% |
| Q3 2021 | $61,000 | -44.5% | 60,000 | 0.0% | 0.03% | -37.8% |
| Q2 2021 | $110,000 | +46.7% | 60,000 | 0.0% | 0.04% | +21.6% |
| Q4 2020 | $75,000 | -30.6% | 60,000 | 0.0% | 0.04% | -43.9% |
| Q3 2020 | $108,000 | -35.7% | 60,000 | +200.0% | 0.07% | -44.1% |
| Q2 2020 | $168,000 | +60.0% | 20,000 | 0.0% | 0.12% | +22.9% |
| Q1 2020 | $105,000 | – | 20,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 397,168 | $43,888 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $3,366 | 0.00% |
| McAdam, LLC | 10,006 | $6 | 0.00% |
| Aries Wealth Management | 15,400 | $1,702 | 0.00% |
| Tekla Capital Management LLC | 154,310 | $17,051 | 0.00% |
| HAP Trading, LLC | 27,600 | $0 | 0.00% |
| ExodusPoint Capital Management, LP | 16,868 | $2 | 0.00% |
| Graypoint LLC | 13,420 | $1,483 | 0.00% |
| Tower Research Capital LLC (TRC) | 56,548 | $6 | 0.00% |
| Kestra Advisory Services, LLC | 16,800 | $1,856 | 0.00% |